The Duke Chronic Thromboembolic Pulmonary Hypertension Program provides focused care for the subset of patients whose pulmonary embolism never resolves.
Chronic thromboembolic pulmonary hypertension (CTEPH) — with or without symptoms — may be present in this patient group, and Duke is one of only a few medical centers in the nation to offer the highly specialized pulmonary thromboendarterectormy as a potential treatment option.
Multi-Faceted Approach to Care and Research
Care for patients with CTEPH, often mistaken for and treated as common pulmonary hypertension, requires a distinct multi-faceted approach.
Duke’s CTEPH Program is leading the way with an interdisciplinary team of pulmonologists specializing in pulmonary hypertension, thoracic surgeons, interventional radiologists, nurses, therapists, and pharmacists.
Duke also collaborates with fellow CTEPH specialists in leading US and international centers and pursues research in an extensive world-class program.
CTEPH Team Members
John A. Haney, MD, MPH
Cardiovascular and Thoracic Surgery
Terry Fortin, MD, MS — Cardiology
Sudarshan Rajagopal, MD, PhD - Cardiology
Talal Dahhan, MD - Pulmonary Vascular Disease Center
Richard A. Krasuski, MD - Cardiology
Lynn M. Koweek, MD - Radiology
David R. Sopko, MD - Interventional Radiology
Thomas L. Ortel, MD, PhD — Hematology
Lacey Washington, MD — Thoracic Radiology
Karla B. Kennedy, RN, BSN - Research Practice Lead
Lisa Carver, RN - CTEPH Coordinator